Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-043886
Filing Date
2026-06-17
Accepted
2026-06-17 16:13:51
Documents
1
Period of Report
2026-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1781727229.html 4  
1 FORM 4 wk-form4_1781727229.xml 4 3879
  Complete submission text file 0001628280-26-043886.txt   5386
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address
Johnson-Greene Treerita Essalima (Reporting) CIK: 0002113708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36751 | Film No.: 261098562